The Neurological Field Continues to Update
In recent years, there has been tremendous growth in new diagnostic information, pharmacological and neurosurgical treatments for neurological disease, as well as a greater understanding of brain function. Our news section informs you of ongoing topics with a potential worldwide influence. In addition to this section, we inform through our social media platforms to keep connect with our member more easier than before.
Our subcategories on News include:
- World Federation of Neurology News
We inform you on our projects and activities, the journal updates, the WFN committee update and more... - Neurology News
Update on interesting news and current activities with worldwide scope. From the history of neurology through the modern technology that shape neurology nowadays.
World Federation of Neurology News
23 Jun 2026
2026 World Brain Day Dedicated to Brain Health: Access For All
8 Jun 2026
Journal of the Neurological Sciences issue 487 now available
2 Jun 2026
eNeurologicalSci (eNS) June 2026 issue
Neurology News
23 Jun 2026
2026 World Brain Day Dedicated to Brain Health: Access For All
LONDON, July 17, 2026 -- The World Federation of Neurology (WFN) is pleased to announce Brain Health: Access for All as the theme for the 2026 World Brain Day. This global campaign aims to raise awareness of the importance of supporting brain health for all.
17 Jun 2026
Real-world timing of early anticoagulation therapy in intracerebral hemorrhage patients with atrial fibrillation: An observat
The efficacy and safety of anticoagulation therapy in patients with concomitant atrial fibrillation and intracerebral hemorrhage remain highly debated, and the optimal timing for resuming treatment is rarely investigated.
11 Jun 2026
Chimeric antigen receptor T-cell therapy in neurological disorders: Emerging applications, evidence, and challenges
CAR T-cell therapy is transitioning from oncology to neuroimmunology, offering a paradigm shift from chronic immunosuppression to long-term immune reconstitution by engineering a patient's own T cells to target pathogenic immune populations.
